Drugs in MeSH Category Phosphodiesterase 5 Inhibitors
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Inc | TADALAFIL | tadalafil | TABLET;ORAL | 205885-002 | Mar 29, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Lupin Ltd | TADALAFIL | tadalafil | TABLET;ORAL | 210567-001 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hetero Labs Ltd V | SILDENAFIL CITRATE | sildenafil citrate | FOR SUSPENSION;ORAL | 213014-001 | May 11, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Reyoung | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 208494-001 | Jun 12, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cmp Dev Llc | LIQREV | sildenafil citrate | SUSPENSION;ORAL | 214952-001 | Apr 28, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Vkt Pharma | TADALAFIL | tadalafil | TABLET;ORAL | 215556-004 | Nov 4, 2021 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Qilu Pharm Hainan | TADALAFIL | tadalafil | TABLET;ORAL | 210420-002 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |